28 May 2026
18:00 CEST |
MEDINCELL S.A. |
Medincell: Videoconference and Publication of Annual Financial Results, Tuesday, June 16, 2026
|
20103010 Biotechnology |
Other subject |
28 May 2026
18:00 CEST |
MEDINCELL S.A. |
Medincell : Vidéoconférence et publication des résultats financiers annuels 2025-26, mardi 16 juin 2026
|
20103010 Biotechnology |
Other subject |
26 May 2026
18:00 CEST |
MEDINCELL S.A. |
Medincell to Participate in Jefferies and Evercore Investor Conferences in the U.S. in June
|
20103010 Biotechnology |
Other subject |
26 May 2026
18:00 CEST |
MEDINCELL S.A. |
Medincell participera en juin aux conférences investisseurs Jefferies et Evercore aux États-Unis
|
20103010 Biotechnology |
Other subject |
21 May 2026
19:24 CEST |
MEDINCELL S.A. |
Medincell : L'Agence européenne des médicaments (EMA) accepte le dossier de demande de mise sur le marché déposée par Teva pour l’Olanzapine LAI
|
20103010 Biotechnology |
New |
21 May 2026
19:24 CEST |
MEDINCELL S.A. |
Medincell: The European Medicines Agency Accepts Teva’s Marketing Authorization Application for Olanzapine Long-Acting Injectable for the Treatment of Schizophrenia in Adults
|
20103010 Biotechnology |
New |
29 Apr 2026
13:39 CEST |
MEDINCELL S.A. |
Medincell - UZEDY®: Q1 2026 Net Sales Reached $63M, Up 62% Year‑on‑Year
|
20103010 Biotechnology |
Other subject |
29 Apr 2026
13:39 CEST |
MEDINCELL S.A. |
Medincell - UZEDY® : 63 M$ de ventes nettes au T1 2026, en hausse de 62% sur un an
|
20103010 Biotechnology |
Other subject |
22 Apr 2026
18:43 CEST |
MEDINCELL S.A. |
La banque européenne Degroof Petercam initie le suivi de Medincell avec une recommandation à l’achat
|
20103010 Biotechnology |
Other subject |
22 Apr 2026
18:43 CEST |
MEDINCELL S.A. |
Degroof Petercam Initiates Medincell’s Coverage with a “Buy” Recommendation
|
20103010 Biotechnology |
Other subject |
21 Apr 2026
18:30 CEST |
MEDINCELL S.A. |
Leerink Partners Initiates Medincell’s Coverage with a “Outperform” Recommendation
|
20103010 Biotechnology |
Other subject |
21 Apr 2026
18:30 CEST |
MEDINCELL S.A. |
La banque américaine Leerink Partners initie le suivi de Medincell avec une recommandation « Surperformance »
|
20103010 Biotechnology |
Other subject |
16 Apr 2026
18:00 CEST |
MEDINCELL S.A. |
Medincell to Host an Online R&D Day on Tuesday, May 12, 2026
|
20103010 Biotechnology |
Other subject |
16 Apr 2026
18:00 CEST |
MEDINCELL S.A. |
Medincell organisera un R&D Day digital le mardi 12 mai 2026
|
20103010 Biotechnology |
Other subject |
02 Apr 2026
19:00 CEST |
MEDINCELL S.A. |
Medincell : Information relative au nombre d’actions composant le capital social et au nombre total des droits de vote
|
20103010 Biotechnology |
Share history |
26 Mar 2026
18:00 CET |
MEDINCELL S.A. |
EIB Waives its Right to Cash Settlement on Medincell Warrants
|
20103010 Biotechnology |
Other subject |
26 Mar 2026
18:00 CET |
MEDINCELL S.A. |
La BEI renonce à son droit au règlement en cash de ses BSA Medincell
|
20103010 Biotechnology |
Other subject |
06 Mar 2026
08:00 CET |
MEDINCELL S.A. |
Medincell annonce le succès de son Placement Privé d’environ 48 millions d’euros
|
20103010 Biotechnology |
Other subject |
06 Mar 2026
08:00 CET |
MEDINCELL S.A. |
Medincell Announces Successful c. €48 Million Private Placement
|
20103010 Biotechnology |
Other subject |
05 Mar 2026
17:35 CET |
MEDINCELL S.A. |
Medincell lance un placement privé auprès d’investisseurs institutionnels internationaux
|
20103010 Biotechnology |
Other subject |
05 Mar 2026
17:35 CET |
MEDINCELL S.A. |
Medincell Launches a Private Placement for International Institutional Investors
|
20103010 Biotechnology |
Other subject |
04 Mar 2026
18:00 CET |
MEDINCELL S.A. |
Medincell to Participate in Leerink and Jefferies Miami Investor Conferences, March 8 – 11, 2026
|
20103010 Biotechnology |
Meetings / events |
04 Mar 2026
18:00 CET |
MEDINCELL S.A. |
Medincell participera aux conférences investisseurs Leerink et Jefferies à Miami, du 8 au 11 mars 2026
|
20103010 Biotechnology |
Meetings / events |
24 Feb 2026
18:00 CET |
MEDINCELL S.A. |
Medincell fera une présentation à TD Cowen 46th Annual Healthcare Conference à Boston, du 2 au 4 mars 2026
|
20103010 Biotechnology |
Other subject |
24 Feb 2026
18:00 CET |
MEDINCELL S.A. |
Medincell to Present at the TD Cowen 46th Annual Healthcare Conference in Boston, March 2-4, 2026
|
20103010 Biotechnology |
Other subject |
20 Feb 2026
21:37 CET |
MEDINCELL S.A. |
Medincell: U.S. Food and Drug Administration (FDA) Accepts Teva’s New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults
|
20103010 Biotechnology |
New |
20 Feb 2026
21:37 CET |
MEDINCELL S.A. |
Medincell : La FDA américaine accepte le dossier de demande de mise sur le marché déposé par Teva pour l’Olanzapine LAI
|
20103010 Biotechnology |
New |
10 Feb 2026
18:00 CET |
MEDINCELL S.A. |
La notation ESG de Medincell relevée par ISS
|
20103010 Biotechnology |
Other subject |
10 Feb 2026
18:00 CET |
MEDINCELL S.A. |
Medincell’s ISS ESG Corporate Rating Upgraded
|
20103010 Biotechnology |
Other subject |
28 Jan 2026
14:04 CET |
MEDINCELL S.A. |
Medincell - UZEDY® : croissance des ventes nettes de 117 M$ en 2024 à 191 M$ en 2025 (+63%)
|
20103010 Biotechnology |
Other subject |
28 Jan 2026
14:04 CET |
MEDINCELL S.A. |
Medincell - UZEDY®: Net Sales Increased from $117M in 2024 to $191M in 2025 (+63%)
|
20103010 Biotechnology |
Other subject |
21 Jan 2026
18:00 CET |
MEDINCELL S.A. |
Medincell : Information relative au nombre d’actions composant le capital social et au nombre total des droits de vote
|
20103010 Biotechnology |
Share history |
20 Jan 2026
18:00 CET |
MEDINCELL S.A. |
Medincell : Bilan semestriel du contrat de liquidité
|
20103010 Biotechnology |
Other subject |
20 Jan 2026
18:00 CET |
MEDINCELL S.A. |
Medincell: Half-year Liquidity Contract Statement
|
20103010 Biotechnology |
Other subject |
12 Jan 2026
18:00 CET |
MEDINCELL S.A. |
Medincell : Publication du calendrier financier 2026
|
20103010 Biotechnology |
Meetings / events |
12 Jan 2026
18:00 CET |
MEDINCELL S.A. |
Medincell: Publication of the 2026 Financial Calendar
|
20103010 Biotechnology |
Meetings / events |
18 Dec 2025
18:00 CET |
MEDINCELL S.A. |
Medincell : Information relative au nombre d’actions composant le capital social et au nombre total des droits de vote
|
20103010 Biotechnology |
Share history |
09 Dec 2025
18:02 CET |
MEDINCELL S.A. |
Medincell Publishes its Consolidated Half-Year Financial Results
|
20103010 Biotechnology |
Commercial results |
09 Dec 2025
18:02 CET |
MEDINCELL S.A. |
Medincell publie ses résultats financiers semestriels consolidés
|
20103010 Biotechnology |
Commercial results |
09 Dec 2025
14:50 CET |
MEDINCELL S.A. |
Medincell’s Partner Teva Pharmaceuticals Announces the New Drug Application1 Submission to U.S. FDA for Olanzapine Extended-Release Injectable Suspension (TEV-'749 / mdc-TJK) for the Once-Monthly Treatment of Schizophrenia in Adults
|
20103010 Biotechnology |
Other subject |
09 Dec 2025
14:50 CET |
MEDINCELL S.A. |
Le partenaire de Medincell, Teva Pharmaceuticals, annonce le dépôt auprès de la FDA américaine d’une demande d’autorisation de mise sur le marché1 pour Olanzapine LAI (TEV‑’749 / mdc‑TJK) [...]
|
20103010 Biotechnology |
Other subject |
01 Dec 2025
18:00 CET |
MEDINCELL S.A. |
Medincell : Vidéoconférence et publication des résultats financiers semestriels, mardi 9 décembre 2025
|
20103010 Biotechnology |
Other subject |
01 Dec 2025
18:00 CET |
MEDINCELL S.A. |
Medincell: Videoconference and Publication of Half-year Financial Results, Tuesday, December 9, 2025
|
20103010 Biotechnology |
Other subject |
27 Nov 2025
18:00 CET |
MEDINCELL S.A. |
Medincell Management to Present at the 8th Annual Evercore Healthcare Conference and at the Piper Sandler 37th Annual Healthcare Conference
|
20103010 Biotechnology |
Other subject |
27 Nov 2025
18:00 CET |
MEDINCELL S.A. |
Medincell participera en décembre aux conférences Evercore Healthcare et Piper Sandler Healthcare
|
20103010 Biotechnology |
Other subject |
24 Nov 2025
18:00 CET |
MEDINCELL S.A. |
Medincell Awarded New Grant to Fight Malaria
|
20103010 Biotechnology |
Other subject |
24 Nov 2025
18:00 CET |
MEDINCELL S.A. |
Medincell : nouvelle subvention pour lutter contre le paludisme
|
20103010 Biotechnology |
Other subject |
13 Nov 2025
18:00 CET |
MEDINCELL S.A. |
L'équipe dirigeante de Medincell participera à une discussion stratégique lors de la conférence Jefferies Healthcare (Londres - 17-20 novembre 2025)
|
20103010 Biotechnology |
Other subject |
13 Nov 2025
18:00 CET |
MEDINCELL S.A. |
Medincell Management to Participate in Fireside Chat at the Jefferies London Healthcare Conference 2025 (London - Nov. 17-20, 2025)
|
20103010 Biotechnology |
Other subject |
11 Nov 2025
08:00 CET |
MEDINCELL S.A. |
Medincell Appoints Dr Grace Kim, Chief Strategy Officer, U.S. Finance, to Advance into Next Stage of US Capital Growth
|
20103010 Biotechnology |
Other subject |